ENTACAPONE
Generic: ENTACAPONE
Lannett CompanyManufacturer
ORALRoute
ENTACAPONEActive Substance
2018-10-03Original Approval
ENTACAPONE is FDA application ANDA206669, sponsored by SUNSHINE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-10-07
Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising PharmaProduct mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and
Class II2021-07-29
Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed by: Major Pharmaceuticals, 17177Failed Dissolution Specifications
Top Reported Reactions
1
FALL
559 reports
2
HALLUCINATION
558 reports
3
DYSKINESIA
517 reports
4
DEATH
400 reports
5
DRUG INEFFECTIVE
395 reports
6
PARKINSON^S DISEASE
327 reports
7
CONFUSIONAL STATE
300 reports
8
GAIT DISTURBANCE
288 reports
9
TREMOR
286 reports
10
ON AND OFF PHENOMENON
274 reports